1. Home
  2. VIRT vs SUPN Comparison

VIRT vs SUPN Comparison

Compare VIRT & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtu Financial Inc.

VIRT

Virtu Financial Inc.

HOLD

Current Price

$41.14

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$53.76

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIRT
SUPN
Founded
2008
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
VIRT
SUPN
Price
$41.14
$53.76
Analyst Decision
Hold
Strong Buy
Analyst Count
7
5
Target Price
$42.71
$61.60
AVG Volume (30 Days)
1.2M
781.0K
Earning Date
04-30-2026
05-21-2026
Dividend Yield
2.30%
N/A
EPS Growth
72.73
6500.00
EPS
5.13
N/A
Revenue
$3,632,118,000.00
$392,755,000.00
Revenue This Year
N/A
$8.18
Revenue Next Year
$4.02
$22.15
P/E Ratio
$8.12
N/A
Revenue Growth
26.25
N/A
52 Week Low
$31.55
$29.16
52 Week High
$45.77
$59.68

Technical Indicators

Market Signals
Indicator
VIRT
SUPN
Relative Strength Index (RSI) 65.78 58.52
Support Level $41.22 $47.95
Resistance Level $42.08 $57.65
Average True Range (ATR) 1.10 2.10
MACD 0.13 0.45
Stochastic Oscillator 81.25 41.19

Price Performance

Historical Comparison
VIRT
SUPN

About VIRT Virtu Financial Inc.

Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: